Statins and neuroprotection: a prescription to move the field forward
about
Management of intracerebral hemorrhage--use of statinsBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs.Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injuryCholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort studyData gaps limit the translational potential of preclinical research.Isoprenoids, small GTPases and Alzheimer's disease.Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells.Hyperlipidemia and statins affect neurological outcome in lumbar spine injuryProspects of statins in Parkinson diseaseStatins and brain integrity in older adults: secondary analysis of the Health ABC studyLipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.Prospective study of statin use and risk of Parkinson disease.Guest editorial: Opportunities in rehabilitation research.Targeted drug delivery to treat pain and cerebral hypoxiaThe failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.Statins, Bcl-2, and apoptosis: cell death or cell protection?Simvastatin protects ischemic spinal cord injury from cell death and cytotoxicity through decreasing oxidative stress: in vitro primary cultured rat spinal cord model under oxygen and glucose deprivation-reoxygenation conditionsHypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.Evidence for the efficacy of statins in animal stroke models: a meta-analysis.Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.Lipid rafts in neurodegeneration and neuroprotection.Impact on cognitive function-are all statins the same?Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.Treatment of acute cerebral ischemia using animal models: a meta-analysis.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.Statin Use and Its Association with Essential Tremor and Parkinson's Disease.HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival.Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Brain Oxidative Stress During Experimental Sepsis Is Attenuated by Simvastatin Administration.Studying neuroprotective effect of Atorvastatin as a small molecule drug on high glucose-induced neurotoxicity in undifferentiated PC12 cells: role of NADPH oxidase.Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home.Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage.Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats
P2860
Q26752952-B4A2A13B-5475-4EEF-A7BA-D682F6314655Q26864317-6F337DBF-41D5-4764-88D3-44642CA3BE57Q27300308-3867F0F1-FFFB-47C7-99C8-6EB511F0668AQ28088708-470F1290-C28B-4509-BBDD-47B64E3C98BAQ28740349-F3E33B4F-BC12-4618-9A45-7025394B2FD0Q31035567-CC7D9F81-316C-4A2D-87CB-211E9E08AD7BQ33915441-2BD08502-50E9-438B-9975-1AEE0C0FA47FQ34031703-E78196F3-E194-4FC0-88A6-A90F679F30C9Q34787972-8C85DB23-5F78-4DAC-BAB1-11ED3F3E7859Q35015086-FB214B3E-AACC-4EF6-B954-B664B103AAA1Q35094028-1EE8FAB1-FCB5-4D3B-8F29-FE38970AA25FQ35843502-953C5E94-BF15-4D1E-8A19-62865117221FQ36052691-477B2654-FFFE-45F4-B52A-B91F360F7156Q36100697-013A1DAA-DC34-48AA-86FA-C9D3F1B29DB2Q36142473-A8EA8D3D-2806-4681-8823-6175B6A2AAFEQ36591611-900F3597-CEB9-48BD-99AA-9364AC0142D9Q36802095-73709A5C-F146-419E-B58D-AB7F827D1F15Q37188822-7B72EF38-D0C0-40DE-939E-462361FAC2CAQ37671313-DA59A783-5E48-4487-8B0B-4D3028D7C8AAQ37695344-6998524E-1470-4FEE-A512-3DAFC313F32CQ38006716-AE21CA25-8316-4B55-B143-B58621DC2389Q38007107-ACF1D300-7195-403B-B8A9-AB05123ABEECQ38173298-35F5822D-96AC-47C4-8918-E45C87DA0ECCQ38268341-30A1A411-A551-4AFA-A46A-A8A680DD18D7Q38272551-6075F8D5-C317-4601-8059-CFFFF6AC2AF6Q38587724-AB50F3DC-7763-427E-8094-9AC119DECB9EQ39042361-92105466-7938-442B-AAA0-3209F0B44ED8Q39348762-DF2F6ADE-9E1D-42D9-BCE2-28EBD415CE25Q39582097-B2C42453-DFF3-4D7A-8E7D-328F728109F7Q39638936-04E4155A-9081-41E0-8986-3E01A91944F5Q40700131-297100B0-9A04-4CC8-AF1C-F0C6F81F70C4Q41082793-CDA8E3DF-2A99-4522-AE84-529A03F47E58Q45201060-4D6721ED-72DF-44C9-812E-38CE19609432Q46467425-86EB3AC4-359E-401F-AFAC-AACDA9C44A7BQ46508181-74E87F54-D545-41D8-9A52-8A0498B74035Q47298592-A3E43D17-0386-4DCD-8AFB-E0958FAD23DBQ48354675-4950168E-FA09-4780-84B4-C1FFA7BB2A27Q50901675-BA688487-FD1F-4BC9-92DA-70CE817A902FQ54223105-11B1BE93-14DB-4058-B269-190EEA37357DQ58744534-7C5618E3-2728-4CF9-B882-DFF0AEF5E84F
P2860
Statins and neuroprotection: a prescription to move the field forward
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Statins and neuroprotection: a prescription to move the field forward
@ast
Statins and neuroprotection: a prescription to move the field forward
@en
Statins and neuroprotection: a prescription to move the field forward
@nl
type
label
Statins and neuroprotection: a prescription to move the field forward
@ast
Statins and neuroprotection: a prescription to move the field forward
@en
Statins and neuroprotection: a prescription to move the field forward
@nl
prefLabel
Statins and neuroprotection: a prescription to move the field forward
@ast
Statins and neuroprotection: a prescription to move the field forward
@en
Statins and neuroprotection: a prescription to move the field forward
@nl
P2093
P2860
P1476
Statins and neuroprotection: a prescription to move the field forward
@en
P2093
Gunter P Eckert
Urule Igbavboa
W Gibson Wood
Walter E Müller
P2860
P356
10.1111/J.1749-6632.2009.05359.X
P407
P577
2010-06-01T00:00:00Z